| 摘要: |
| 目的 介绍多西紫杉醇联合化疗法治疗非小细胞肺癌的研究进展。方法 通过查阅国内外的文献资料，讨论多西紫杉醇联合铂类制剂和非铂类第3代药物的临床疗效和不良反应。结果 多西紫杉醇联合化疗法治疗非小细胞肺癌疗效确切、不良反应轻微。结论 联合化疗方案有望解决单药方案有效率略低的问题，并为非小细胞肺癌的治疗提供临床指导。 |
| 关键词: 非小细胞肺癌 多西紫杉醇 联合治疗 |
| DOI： |
| 分类号: |
| 基金项目:广西自然科学基金重点项目(2010GXNSFD013040) |
|
| Progress of Docetaxel Combining with Chemotherapy in Treatment of Non-small Cell Lung Cancer |
|
ZHAO Shufang, WANG Lisheng
|
|
School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China
|
| Abstract: |
| OBJECTIVE To introduce the progress of the combined treatment of docetaxel and chemotherapy for non-small cell lung cancer. METHODS By investigating the national and international literatures, the clinical effects and adverse reactions of docetaxel combining with platinum agents and non-platinum drugs were discussed. RESULTS The efficacy was definite and adverse effects were light in treatment of non-small cell lung cancer by docetaxel combining with chemotherapy. CONCLUSION The combined therapy is expected to solve the single-agent problem of low effects and provide the clinical guidance. |
| Key words: non-small cell lung cancer docetaxel combination therapy |
